Literature DB >> 8503824

S-adenosyl-L-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms.

B G Crowell1, R Benson, D Shockley, C G Charlton.   

Abstract

S-Adenosyl-L-methionine has been shown to cause Parkinson's disease-like effects that include hypokinesia, tremor, rigidity, and abnormal posture. S-Adenosyl-L-methionine is the rate-limiting endogenous methyl donor. Its biochemical role, which includes the metabolism of dopamine and the synthesis of acetylcholine, also resembles the changes that occur in Parkinson's disease. Therefore, S-adenosyl-L-methionine may play a role in Parkinson's disease-like motor impairments. In this study we manipulated the levels of S-adenosyl-L-methionine in the brain of rats and quantified the changes in hypokinetic type motor activity that seems to occur also in Parkinsonism. Male Sprague-Dawley rats were anesthetized with chloral hydrate (400 mg/kg/rat), cannulated, injected into the lateral ventricle with S-adenosyl-L-methionine or saline, and their motor activity was measured in a Digiscan Animal Activity Monitor. Other behaviors were also observed. S-Adenosyl-L-methionine caused hypokinesia, tremor, rigidity, and abnormal posture in rats. Motor activity was significantly decreased within 2 min postinjection. The hypokinesia was maximal at 60 min, at which time a 65, 75, and 90% decrease for total distance, number of movements, and the ratio of total distance to the number of movements occurred, respectively. The hypokinetic effect of S-adenosyl-L-methionine was dose dependent. A 65.0 and 51.3% decrease in total distance and number of movements, respectively, were observed following 9.38 x 10(-9) mol. The 5.0 x 10(-8) mol caused a reduction of 73.42 and 57.66% and 4.0 x 10(-7) mol/rat caused a 94.9 and 78.43% decrease, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503824     DOI: 10.1016/0163-1047(93)90950-m

Source DB:  PubMed          Journal:  Behav Neural Biol        ISSN: 0163-1047


  6 in total

1.  Inhibitory effects of lysophosphatidylcholine on the dopaminergic system.

Authors:  Eun-Sook Y Lee; Hongtao Chen; Kennie R Shepherd; Nazarius S Lamango; Karam F A Soliman; Clivel G Charlton
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

2.  Excessive S-adenosyl-L-methionine-dependent methylation increases levels of methanol, formaldehyde and formic acid in rat brain striatal homogenates: possible role in S-adenosyl-L-methionine-induced Parkinson's disease-like disorders.

Authors:  Eun-Sook Lee; Hongtao Chen; Chadwick Hardman; Anthony Simm; Clivel Charlton
Journal:  Life Sci       Date:  2008-10-05       Impact factor: 5.037

3.  Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism.

Authors:  C G Charlton; J Mack
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

4.  Comprehensive serum metabolic and proteomic characterization on cognitive dysfunction in Parkinson's disease.

Authors:  Na Zhang; Chuanxi Tang; Qiong Ma; Wei Wang; Mingyu Shi; Xiaoyu Zhou; Fangfang Chen; Chengcheng Ma; Xue Li; Gang Chen; Dianshuai Gao
Journal:  Ann Transl Med       Date:  2021-04

5.  Tremorgenic effects and functional metabolomics analysis of lolitrem B and its biosynthetic intermediates.

Authors:  Priyanka Reddy; Simone Rochfort; Elizabeth Read; Myrna Deseo; Emily Jaehne; Maarten Van Den Buuse; Kathryn Guthridge; Martin Combs; German Spangenberg; Jane Quinn
Journal:  Sci Rep       Date:  2019-06-27       Impact factor: 4.379

6.  Methylation reactions at dopaminergic nerve endings, serving as biological off-switches in managing dopaminergic functions.

Authors:  Clivel G Charlton
Journal:  Neural Regen Res       Date:  2014-06-01       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.